Simoa Success Grant Proposal 2: Assay Development Application
Infectious Disease/Immunology Assay Development Award
Learn more about the Simoa Success Assay Development Award
Quanterix announces the Simoa Success Grant Program in support of investigators based in the United States who are studying critical topics at the intersection of laboratory and clinical research in Infectious Diseases and Immunology to introduce them to the benefits of Simoa assays for protein biomarker analysis.
Applicants are encouraged to present a plan for development of a novel Simoa assay utilizing the Quanterix SP-X platform and “Homebrew” assay kit. SP-X homebrew assays follow a sandwich ELISA format and require two target-specific antibodies, recognizing different epitopes. Assay development will also require a positive control sample, such as recombinant target protein, that can be diluted to generate a calibration curve. Proposals improving assay performance with a proven set of antibodies and calibrator from an existing ELISA that requires additional sensitivity will be considered less risky than those involving de novo use of reagent combinations. Preferred projects will address a need for high-sensitivity/specificity protein detection supporting diagnosis, prognosis, or treatment efficacy/kinetics/safety studies for diseases engaging the immune system. Analysis of up to 60 unique samples to show utility of the novel assay for a specific application may be included as part of the proposal.
Grant applications must be submitted by 5 p.m. EDT on June 19, 2020. Candidates will be notified by July 3, 2020 if their application has been selected for a Quanterix Simoa Success award. Submit your applications to SimoaGrant@quanterix.com
Access the full list of rules and regulations here.
Decision of the judges is final. Terms and conditions are subject to change without notice. Void where prohibited by law.